PT-141
Metabolic Peptides
Also known as: Bremelanotide, Vyleesi
A synthetic peptide derived from Melanotan II, researched for its effects on sexual function through central nervous system pathways.
- Dose in studies
- 1-2 mg as needed (30-60 min before activity)
- Frequency
- As needed, at least 24h between doses
- Cycle length
- As needed, no cycling required
- Half-life
- ~2-4 hours
- Research level
- 4/5 – Well researched
Frequently asked questions about PT-141
What is PT-141?
A synthetic peptide derived from Melanotan II, researched for its effects on sexual function through central nervous system pathways.
What is the half-life of PT-141?
The half-life of PT-141 is ~2-4 hours.
What dosage of PT-141 has been studied?
Described in research: 1-2 mg as needed (30-60 min before activity), frequency: As needed, at least 24h between doses. This is not a medical recommendation.
How long is a PT-141 cycle?
Typical cycle length in studies: As needed, no cycling required.
What are the side effects of PT-141?
Nausea: The most common side effect, affecting 30-40% of users. Usually mild and transient (30-60 minutes). Anti-nausea medication (ondansetron) before dosing can help. Severity decreases with repeated use. · Facial flushing: Warmth and redness of the face lasting 1-3 hours. Harmless but cosmetically noticeable. More pronounced with higher doses. · Headache: Moderate headache in ~15% of users.…
How well researched is PT-141?
Well researched (4/5). Large phase 3 trials or regulatory approval; long-term data still limited.